Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
PCB Bancorp
PCB
$394M
| $824K | ﹤0.01% |
56,901
-35,097
| -38% | -$606K |
|
|
PARAA
2602
DELISTED
Paramount Global Class A
PARAA
| $822K | ﹤0.01% |
31,803
-6,200
| -16% | -$154K |
|
2603
Colony Bankcorp
CBAN
$465M
| $818K | ﹤0.01% |
80,178
+2,000
| +3% | +$24.3K |
|
|
NEUE
2604
DELISTED
NeueHealth
NEUE
| $818K | ﹤0.01% |
46,398
+39,374
| +561% | +$2.03M |
|
2605
Direxion Daily Energy Bull 2X ETF
ERX
$227M
| $816K | ﹤0.01% |
14,000
+8,200
| +141% | +$515K |
|
|
ADVM
2606
DELISTED
Adverum Biotechnologies
ADVM
| $815K | ﹤0.01% |
113,674
+6,250
| +6% | +$44.2K |
|
2607
Corporacion America
CAAP
$4.18B
| $815K | ﹤0.01% |
80,100
+45,900
| +134% | +$436K |
|
2608
iShares MSCI EAFE Growth ETF
EFG
$16.7B
| $815K | ﹤0.01% |
8,700
+2,560
| +42% | +$230K |
|
2609
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.63B
| $815K | ﹤0.01% |
21,800
+8,400
| +63% | +$323K |
|
|
DALN
2610
DELISTED
DallasNews
DALN
| $814K | ﹤0.01% |
184,051
-600
| -0.3% | -$2.73K |
|
2611
NWPX Infrastructure Inc
NWPX
$1.23B
| $812K | ﹤0.01% |
+26,000
| New | +$938K |
|
2612
Sonic Automotive
SAH
$2.76B
| $810K | ﹤0.01% |
+14,900
| New | +$802K |
|
2613
Dimensional International Small Cap Value ETF
DISV
$4.98B
| $809K | ﹤0.01% |
34,000
+996
| +3% | +$23.6K |
|
2614
Butterfly Network
BFLY
$2.19B
| $805K | ﹤0.01% |
428,300
-197,300
| -32% | -$461K |
|
|
OPI
2615
DELISTED
Office Properties Income Trust
OPI
| $805K | ﹤0.01% |
65,455
+45,500
| +228% | +$699K |
|
2616
ReNew
RNW
$2.29B
| $804K | ﹤0.01% |
143,000
-18,200
| -11% | -$97.2K |
|
|
CLPR
2617
Clipper Realty
CLPR
$44.4M
| $801K | ﹤0.01% |
139,557
+700
| +0.5% | +$4.64K |
|
2618
Smartbird Inc
BIRD
$19.8M
| $800K | ﹤0.01% |
33,326
+7,516
| +29% | +$346K |
|
2619
iShares MSCI Europe Financials ETF
EUFN
$4.25B
| $800K | ﹤0.01% |
42,800
-45,100
| -51% | -$866K |
|
|
ASM
2620
Avino Silver & Gold Mines
ASM
$969M
| $799K | ﹤0.01% |
903,100
+108,700
| +14% | +$81.9K |
|
|
TUYA
2621
Tuya Inc
TUYA
$1.06B
| $799K | ﹤0.01% |
422,700
-4,300
| -1% | -$9.71K |
|
2622
First US Bancshares
FUSB
$92.6M
| $798K | ﹤0.01% |
106,721
-3,400
| -3% | -$30.4K |
|
2623
BorgWarner
BWA
$13B
| $795K | ﹤0.01% |
+18,401
| New | +$762K |
|
|
RVLP
2624
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $795K | ﹤0.01% |
697,415
-17,800
| -2% | -$21.4K |
|
2625
Prelude Therapeutics
PRLD
$350M
| $789K | ﹤0.01% |
138,500
+2,000
| +1% | +$12.2K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.